Researchers have found that there is a strong association between lung tissue with human papillomavirus (HPV) infection.
Patients with lung cancer that have developed resistance to the drug gefitinib experience no statistically significant improvement in progression-free survival when continued use of the drug with chemotherapy is utilized.
A new drug, anamorelin, has been found to improve appetite and body mass in patients with advanced lung cancer who are experiencing cancer anorexia and cachexia.
The pros and cons of low-dose computed tomography (CT) screening for lung cancer are evlauated in relation to the Centers for Medicaid & Medicare Services (CMS) evaluation of screening coverage.
Treatment with the drug crizotinib has been effective for stopping lung tumor growth driven by rearrangements of the ROS1 gene.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|